Sector portfolio · VC firm · United States

Adams Street Partners' Biotech portfolio

Adams Street Partners has backed 17 Biotech startups in rounds we track, $1.6B between them, shown by the stage each has reached. The best-funded is Billiontoone.

17startups backed
4stages
$1.6Braised between them
Series Abiggest stage

Adams Street Partners's whole portfolioAdams Street Partners's profile

Series A

7

Series C and later

4

Stage not reported

3

Series B

3

Segment by segment

Series A

7 startups · $423M raised

  1. IcosavaxIcosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.United States$119M
  2. Fusion PharmaceuticalsFusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.Canada$85M
  3. Epirium BioEpirium Bio is a clinical-stage biopharmaceutical company based in San Diego, California.United States$85M
  4. Partner TherapeuticsPTx is a biopharmaceutical company committed to the development and commercialization of therapies that improve the treatment of cancer.United States$60M
  5. QQpexUnited States$33M
  6. FusionVC & accelerator for Israeli start-ups in the US.Canada$21M
  7. Outpost MedicineOutpost Medicine is a biopharmaceutical companyUnited Kingdom$20M

Series C and later

4 startups · $466M raised

  1. Reify HealthReify Health is a Boston-based company that provides cloud-based software solutions for the clinical trial ecosystem.United States$220M
  2. CareCloudCareCloud, Inc., formerly MTBC, provides cloud-based technology-enabled software and services for medical practices in the US.United States$130M
  3. RedoxRedox, also known as Redox Engine, is a technology company based in Madison, Wisconsin, specializing in healthcare data interoperability.United States$58M
  4. TriReme MedicalTriReme Medical develops novel stent technologies for the treatment of coronary artery bifurcations.United States$58M

Stage not reported

3 startups · $499M raised

  1. BillionToOneBillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.United States$280M
  2. Palvella TherapeuticsPalvella Therapeutics is a clinical-stage biopharmaceutical company based in Wayne, Pennsylvania.United States$210M
  3. healthfinchHealthfinch is an automation platform that uses EMR data to provide its users with electronic health record applications.United States$9.1M

Series B

3 startups · $207M raised

  1. FPFusion PharamaceuticalsCanada$105M
  2. AptinyxAptinyx Inc.United States$76M
  3. MyHealthTeamsMyHealthTeams creates social networks for chronic condition communities.United States$27M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Adams Street Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Adams Street Partners88 co-investorsPortfolio mapAdams Street Partners portfolio map71 startups · $17BSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179B

Raising from investors like Adams Street Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps